Australia mRNA Therapeutics Market Size and Forecast to 2035 by Application and Disease Indication | 19% CAGR Drives USD 1.78 Billion Opportunity Across Influenza and RSV
Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personalized medicine Government support, private-public investment, global collaborations and a rich mRNA pipeline create opportunities across vaccines, oncology and personal…
Short extract only — this publisher licenses its text. Read the full release at the source.
Cancel anytime · CA$99/month


